论文部分内容阅读
目的:观察注射用黄芪多糖联合化疗治疗恶性肿瘤的临床疗效。方法:将应用注射用黄芪多糖配合化疗治疗恶性肿瘤的患者,与常规化疗组患者对照,进行临床疗效观察。结果:治疗组治疗前后白细胞变化比较无显著性差异,而对照组下降明显,治疗前后比较有显著性差异(P<0.01),对照组治疗后白细胞数较治疗组有显著性差异(P<0.01);治疗组的实体瘤疗效为70%,对照组为50%,两组比较有显著性差异(P<0.05);治疗组的生活质量卡氏评分的有效率为70%,对照组为45%,两组比较有显著性差异(P<0.05)。结论:化疗联用黄芪多糖,可显著减少化疗期间骨髓抑制,提高化疗患者的临床疗效,改善患者生活质量。
Objective: To observe the clinical efficacy of injection of astragalus polysaccharide combined with chemotherapy in the treatment of malignant tumors. Methods: The application of Astragalus polysaccharide injection combined with chemotherapy for the treatment of malignant tumors in patients with conventional chemotherapy control, clinical efficacy. Results: There was no significant difference in leukocyte before and after treatment between the treatment group and the control group, but there was a significant difference between before and after treatment (P <0.01). The number of leukocytes in the control group was significantly different from that in the control group (P <0.01) ). The effective rate of the treatment group was 70% for the solid tumor and 50% for the control group, with significant difference between the two groups (P <0.05); the effective rate of the quality of life score of the treatment group was 70% and that of the control group was 45% %, There was significant difference between the two groups (P <0.05). Conclusion: Astragalus polysaccharide combined with chemotherapy can significantly reduce bone marrow suppression during chemotherapy, improve the clinical efficacy of chemotherapy patients, and improve the quality of life of patients.